Adhesion molecules: a new target for immunoliposome-mediated drug delivery.
about
Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications.Microbubbles in ultrasound-triggered drug and gene deliveryLiposomes in diagnosis and treatment of cardiovascular disorders.Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature.Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta modelTargeted delivery of therapeutics to endothelium.Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriersPreparation and in vitro evaluation of anti-VCAM-1-Fab'-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib.Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriersTargeting antioxidant and antithrombotic biotherapeutics to endothelium.Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.Designing of 'intelligent' liposomes for efficient delivery of drugs.A fibrinogen-derived peptide provides intercellular adhesion molecule-1-specific targeting and intraendothelial transport of polymer nanocarriers in human cell cultures and miceImmunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular systemBiological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.Recent advances in tumor vasculature targeting using liposomal drug delivery systems.Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.New biotechnological and nanomedicine strategies for treatment of lysosomal storage disordersDynamic factors controlling targeting nanocarriers to vascular endothelium.Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies.Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors.Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent.Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease.Biodistribution study of doxorubicin encapsulated in liposomes: influence of peptide coating and lipid composition.Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells.Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress.Synthetic microvascular networks for quantitative analysis of particle adhesion.Limited adhesion of biodegradable microspheres to E- and P-selectin under flow.Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins.Coupling of metal containing homing devices to liposomes via a maleimide linker: use of TCEP to stabilize thiol-groups without scavenging metals.Uptake and intracellular processing of PEG-liposomes and PEG-immunoliposomes by kupffer cells in vitro 1 *.Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials.Fluorescence Microscopy Imaging Calibration for Quantifying Nanocarrier Binding to Cells During Shear Flow Exposure.Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits.
P2860
Q30364399-374C1666-9A44-439A-A603-17B2403116C5Q30438994-2882A5BA-C1BA-4E78-B9D5-AAFFF80329F3Q30464757-2B2D9075-470A-4AA1-8430-5B9E8DC28B18Q30475080-BA939DFC-36FD-4521-BB73-BA73871524C4Q30475139-1EBB6749-908B-4206-98CD-573A3AD2C563Q30475849-40CAF492-268D-4544-9343-EE96C29D7F98Q33606794-9D6E1B94-B588-4F8C-922D-41BA16EC71D2Q33852343-C8EA53DF-AB51-4394-9632-FD09373B52FCQ34690444-D95D5D0D-672E-456F-B69F-622C38897685Q34935960-F885A9D0-F127-4C5B-83DE-FD2C06CE9F34Q35001301-3C617CB4-EE58-46BE-862A-B80BB8A665BBQ35075383-E1250A4F-85F7-4969-A2DA-75B4508AD100Q35776839-06DAA252-9C0B-4BD6-A7E9-1CA09750CD15Q36560724-ECBFA6C6-5D26-4B1D-8866-FABA5D816F1DQ37514889-DE6C7EAD-484F-4F4F-A4E3-608107306DEEQ37603355-083CEBE2-83BF-469C-B405-E33ECB968FBDQ37672410-B6476416-0EDC-4DAA-BBC2-59A9C39C1E4AQ37683644-70B66173-6C38-49A2-841D-BA5E63756816Q37980236-B05E2FFA-ACAB-4BEE-A1E1-DEA1989FB8D8Q38151092-70A65F81-C10E-4E70-BF8F-125A3D80AA06Q38207560-471112E9-67D2-4B79-9AC9-BB68894B05C8Q38684097-2AC88D73-A793-48A2-8E0E-F466E0267FCBQ39273796-9261DC45-3920-49EF-A3F1-ECA154FB2D6FQ39328028-9DCA4E22-93B9-4C68-A94C-E7924790C3F0Q39636269-27529E36-29F3-45FB-9951-21DE194F685CQ40522083-109C0AE1-515A-4C13-AA84-D3220BDEB15EQ40923925-C0BEA431-98E9-4A25-A147-1A91BD1A64B0Q41824469-22DAAD59-B2A6-451F-9BA7-5FBAC6166FCFQ41915532-F1AF965A-A44F-4C5E-A9D3-BED8A699156AQ42037516-1855020D-8571-482E-A6C5-13C3A2E909DDQ43602024-996AEC99-A62A-4AAD-BB53-D18585C5542DQ44849271-A1555981-3C76-45C7-837D-8E1DAD9EF7A6Q45204021-D32C23BB-6CDA-42B4-93FB-A5F8AB773AA4Q45967329-CD72B603-9D59-4305-A819-757D972A9901Q47169530-6A15D7DD-376B-4A54-8688-7BDAF20555E0Q50147160-2F54FD74-689F-4CC5-B6D8-5A60490ECB6BQ50239899-9C4F580E-72CF-471D-891F-A2ED473D5EE3
P2860
Adhesion molecules: a new target for immunoliposome-mediated drug delivery.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Adhesion molecules: a new target for immunoliposome-mediated drug delivery.
@en
type
label
Adhesion molecules: a new target for immunoliposome-mediated drug delivery.
@en
prefLabel
Adhesion molecules: a new target for immunoliposome-mediated drug delivery.
@en
P2093
P2860
P1433
P1476
Adhesion molecules: a new target for immunoliposome-mediated drug delivery.
@en
P2093
Bloemen PG
Crommelin DJ
Henricks PA
Nijkamp FP
van Bloois L
van den Tweel MC
P2860
P304
P356
10.1016/0014-5793(94)01350-A
P407
P577
1995-01-01T00:00:00Z